# Bolt Biotherapeutics, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 16:05 ET
- Period: 2026-06-11
- Accession: 0001193125-26-267487
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000119312526267487/bolt-20260611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000119312526267487/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000119312526267487/bolt-20260611.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-267487. Last ingested by Listed: Nov 13, 2026, 14:24 ET. No prices; not investment advice.